Rene Russo
Officer, X4 Pharmaceuticals, Inc.
Companies
- Xilio Therapeutics, Inc.Board member Oct 21, 2021 to now1
- Xilio Therapeutics, Inc.Chief executive officer Oct 21, 2021 to now1
- Xilio Therapeutics, Inc.President Oct 21, 2021 to now1
- Invivyd, Inc.Board member Aug 5, 2021 to Aug 9, 20212
- X4 Pharmaceuticals, IncBoard member Nov 15, 2017 to Jun 2, 20213
- X4 Pharmaceuticals, IncChief executive officer Mar 9, 2018 to Mar 9, 20184
- X4 Pharmaceuticals, IncPresident Mar 9, 2018 to Mar 9, 20184
- X4 Pharmaceuticals, IncOfficer Nov 15, 2017 to Nov 15, 20173
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Xilio Therapeutics, Inc. XLO325,422 shares5$2.9M at $9.05Jan 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 1, 2026Exercised options 44,250 shares of Xilio Therapeutics, Inc.5
- Jun 16, 2025Bought 36,289 shares at $0.68 of Xilio Therapeutics, Inc.6
- Jan 1, 2025Exercised options 44,250 shares of Xilio Therapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARInvivyd, Inc., Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Jun 18, 2025
- 7SEC EDGARForm 4 filed Jan 3, 2025